139 related articles for article (PubMed ID: 2428638)
1. The putative prostacyclin receptor antagonist (FCE-22176) is a full agonist on human platelets and NCB-20 cells.
Wilkins AJ; MacDermot J
Eur J Pharmacol; 1986 Aug; 127(1-2):117-9. PubMed ID: 2428638
[TBL] [Abstract][Full Text] [Related]
2. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
3. Identification of the prostacyclin receptor by radiation inactivation.
Leigh PJ; Cramp WA; MacDermot J
J Biol Chem; 1984 Oct; 259(20):12431-6. PubMed ID: 6208187
[TBL] [Abstract][Full Text] [Related]
4. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of prostacyclin responsiveness in a neuronal hybrid cell line: selective loss of high affinity receptors.
Leigh PJ; MacDermot J
Br J Pharmacol; 1985 May; 85(1):237-47. PubMed ID: 2992650
[TBL] [Abstract][Full Text] [Related]
6. Desensitization of prostacyclin receptors in a neuronal hybrid cell line.
Blair IA; Leigh PJ; MacDermot J
Br J Pharmacol; 1982 Sep; 77(1):121-7. PubMed ID: 6289953
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
Armstrong RA; Jones RL; MacDermot J; Wilson NH
Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
[TBL] [Abstract][Full Text] [Related]
8. Segregation of discrete GS alpha-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids.
Kelly E; Keen M; Nobbs P; MacDermot J
Br J Pharmacol; 1990 Feb; 99(2):309-16. PubMed ID: 1691675
[TBL] [Abstract][Full Text] [Related]
9. Desensitization of prostacyclin responsiveness in platelets. Apparent differences in the mechanism in vitro or in vivo.
MacDermot J
Biochem Pharmacol; 1986 Aug; 35(16):2645-9. PubMed ID: 2427086
[No Abstract] [Full Text] [Related]
10. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase.
Trist DG; Collins BA; Wood J; Kelly MG; Robertson AD
Br J Pharmacol; 1989 Feb; 96(2):301-6. PubMed ID: 2466517
[TBL] [Abstract][Full Text] [Related]
11. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells.
Hall JM; Strange PG
Biosci Rep; 1984 Nov; 4(11):941-8. PubMed ID: 6084527
[TBL] [Abstract][Full Text] [Related]
12. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion.
Darius H; Binz C; Veit K; Fisch A; Meyer J
J Am Coll Cardiol; 1995 Sep; 26(3):800-6. PubMed ID: 7543911
[TBL] [Abstract][Full Text] [Related]
13. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships associated with 3,4,5-triphenyl-1H-pyrazole-1-nonanoic acid, a nonprostanoid prostacyclin mimetic.
Meanwell NA; Rosenfeld MJ; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Seiler SM
J Med Chem; 1992 Jan; 35(2):389-97. PubMed ID: 1370696
[TBL] [Abstract][Full Text] [Related]
15. Internalization and down-regulation of the prostacyclin receptor in human platelets.
Giovanazzi S; Accomazzo MR; Letari O; Oliva D; Nicosia S
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):71-7. PubMed ID: 9224631
[TBL] [Abstract][Full Text] [Related]
16. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
Merritt JE; Brown AM; Bund S; Cooper DG; Egan JW; Hallam TJ; Heagerty AM; Hickey DM; Kaumann AJ; Keen M
Br J Pharmacol; 1991 Jan; 102(1):260-6. PubMed ID: 2043927
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase.
Jaschonek K; Faul C; Schmidt H; Renn W
Eur J Pharmacol; 1988 Mar; 147(2):187-96. PubMed ID: 2452749
[TBL] [Abstract][Full Text] [Related]
18. Induction of prostacyclin receptor expression in human erythroleukemia cells.
Murray R; Furci L; FitzGerald GA
FEBS Lett; 1989 Sep; 255(1):172-4. PubMed ID: 2477277
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin (PGI) receptor binding and cyclic AMP synthesis activities of PGI1 analogues, SM-10906 and its methyl ester, SM-10902, in mastocytoma P-815 cells.
Oka M; Negishi M; Yamamoto T; Satoh K; Hirohashi T; Ichikawa A
Biol Pharm Bull; 1994 Jan; 17(1):74-7. PubMed ID: 7511960
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin.
Alvarez R; Eglen RM; Chang LF; Bruno JJ; Artis DR; Kluge AF; Whiting RL
Prostaglandins; 1991 Aug; 42(2):105-19. PubMed ID: 1775633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
